Bill Text: KS SB236 | 2023-2024 | Regular Session | Introduced


Bill Title: Requiring drug manufacturers to provide pricing under the federal 340B drug pricing program to pharmacies that enter into contractual agreements with entities covered under the 340B program and prohibiting pharmacy benefits managers from denying patients the freedom to use the pharmacy and healthcare provider of such patient's choice.

Spectrum: Committee Bill

Status: (Failed) 2024-04-30 - Senate Died in Committee [SB236 Detail]

Download: Kansas-2023-SB236-Introduced.pdf
It appears your computer is unable to display this document, however you can download the file from the links above.
feedback